Search alternatives:
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), rc decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 761 - 780 results of 102,650 for search '(( 5 ((ng decrease) OR (mean decrease)) ) OR ( 5 ((c decrease) OR (a decrease)) ))', query time: 1.92s Refine Results
  1. 761
    Brain uptake of [<sup>14</sup>C]docosahexaenoic acid (DHA) in 2-, 8-, 12-, and 24-month-old mice.

    Brain uptake of [<sup>14</sup>C]docosahexaenoic acid (DHA) in 2-, 8-, 12-, and 24-month-old mice. by Takuro Iwao (14636741)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  2. 762
    Decreased neutrophils in <i>MiR125a</i><sup><i>-/-</i></sup> mice.

    Decreased neutrophils in <i>MiR125a</i><sup><i>-/-</i></sup> mice. by Yuting Qin (1950118)

    Published 2017
    Save to List
    Saved in:
  3. 763
    Sudachitin decreases osteoclastogenesis induced by RANKL in cultures of osteoclast precursors.

    Sudachitin decreases osteoclastogenesis induced by RANKL in cultures of osteoclast precursors. by Yoko Ohyama (4775400)

    Published 2018
    Save to List
    Saved in:
  4. 764
    Cellular uptake of [<sup>14</sup>C]docosahexaenoic acid (DHA) by RBECs transfected with MFSD2A siRNA.

    Cellular uptake of [<sup>14</sup>C]docosahexaenoic acid (DHA) by RBECs transfected with MFSD2A siRNA. by Takuro Iwao (14636741)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  5. 765
    Exogenous FGF4 decreases osteogenic differentiation of mESCs.

    Exogenous FGF4 decreases osteogenic differentiation of mESCs. by Sung-Ho Kook (445098)

    Published 2013
    Save to List
    Saved in:
  6. 766
    Decrease of mitochondrial protein levels in human OPMD muscle biopsies.

    Decrease of mitochondrial protein levels in human OPMD muscle biopsies. by Aymeric Chartier (713911)

    Published 2015
    Save to List
    Saved in:
  7. 767
    Plasma CNAs levels decrease after anti-malarial chemotherapy.

    Plasma CNAs levels decrease after anti-malarial chemotherapy. by Bernardo S. Franklin (220946)

    Published 2011
    Save to List
    Saved in:
  8. 768
    C/EBPα binds five sites within the <i>Cebpa</i> +8 kb enhancer.

    C/EBPα binds five sites within the <i>Cebpa</i> +8 kb enhancer. by Lei Peng (260321)

    Published 2019
    Subjects:
    Save to List
    Saved in:
  9. 769
    Decrease of GFP-TbAtg8 fluorescence during starvation.

    Decrease of GFP-TbAtg8 fluorescence during starvation. by Remo S. Schmidt (546946)

    Published 2014
    Save to List
    Saved in:
  10. 770
    The decrease of C/EBPα protein during apoptosis involves induction of protein degradation and inhibition of transcription.

    The decrease of C/EBPα protein during apoptosis involves induction of protein degradation and inhibition of transcription. by Meng Zhao (54299)

    Published 2009
    “…Folds of decrease of C/EBPα protein/β-actin ratios against untreated cells are shown as means±SD of three independent experiments. …”
    Save to List
    Saved in:
  11. 771
    Exogenous activation of BMP signaling decreases apoptosis in POb cells.

    Exogenous activation of BMP signaling decreases apoptosis in POb cells. by Shuli Li (24534)

    Published 2013
    “…<p>(A) Histogram illustrating a time-course of Caspase-3 activity performed on FOb and POb cells undergoing osteogenic differentiation with or without exogenous BMP-2 (200 ng/ml). …”
    Save to List
    Saved in:
  12. 772
    Decrease in GABA<sub>B</sub> expression in APP mice.

    Decrease in GABA<sub>B</sub> expression in APP mice. by Ksenia V. Kastanenka (3692380)

    Published 2017
    Save to List
    Saved in:
  13. 773
    Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments).

    Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 774
    Antibody and antigen responses to Ensovibep vs placebo day 1–90.

    Antibody and antigen responses to Ensovibep vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 775
    Antibody and antigen responses to Lufotrelvir vs placebo day 1–90.

    Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 776
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 777
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 778
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 779
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 780
    Study Flow Diagram.

    Study Flow Diagram. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: